Targeting NPM1 in AML with a menin inhibitor; in primates, a CD137 ADC eliminates acute GVHD
This episode discusses targeting NPM1 in acute myeloid leukemia, with researchers reporting the first clinical evidence of menin inhibitor-induced complete remissions. It also covers targeting CD137 to prevent graft-versus-host disease using an antibody-drug conjugate in…